Jean‐Pierre Vilque

1.5k total citations
18 papers, 254 citations indexed

About

Jean‐Pierre Vilque is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Jean‐Pierre Vilque has authored 18 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jean‐Pierre Vilque's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Jean‐Pierre Vilque is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Jean‐Pierre Vilque collaborates with scholars based in France, Switzerland and Luxembourg. Jean‐Pierre Vilque's co-authors include Anne‐Claire Gac, Éric Deconinck, Ghandi Damaj, Philippe Casassus, Denis Guyotat, François Guilhot, Bruno Lioure, B. Audhuy, Sylvain Chantepie and Jean‐Luc Harousseau and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Jean‐Pierre Vilque

18 papers receiving 248 citations

Peers

Jean‐Pierre Vilque
Comparison fields: 5 of 38
  • Oncology 126
  • Hematology 78
  • Pathology and Forensic Medicine 72
  • Genetics 45
  • Radiology, Nuclear Medicine and Imaging 41
Jodi V. Mones United States
Ingrid Vášová Czechia
Barbara Sosnowska‐Pasiarska Poland
H Seifert Switzerland
Avyakta Kallam United States
Mohamed Touati Morocco
Güner Hayri Özsan Türkiye
Granada Perea Spain
Anna Christoforidou Greece
Konstantinos Christofyllakis Germany
Jodi V. Mones United States View profile →
Citations per field, relative to Jean‐Pierre Vilque
Jean‐Pierre Vilque · 1×
Citations per year, relative to Jean‐Pierre Vilque
Jean‐Pierre Vilque · 1×

Countries citing papers authored by Jean‐Pierre Vilque

Since Specialization
Citations

This map shows the geographic impact of Jean‐Pierre Vilque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Vilque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Vilque more than expected).

Fields of papers citing papers by Jean‐Pierre Vilque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Vilque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Vilque. The network helps show where Jean‐Pierre Vilque may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Vilque

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Vilque. A scholar is included among the top collaborators of Jean‐Pierre Vilque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Vilque. Jean‐Pierre Vilque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Title Journal Authors Indexed citations
1 Diagnostic value of baseline 18FDG PET/CT skeletal textural features in follicular lymphoma Scientific Reports Nicolas Aide, Anne‐Claire Gac et al. 14
2 Single-Unit Transfusion Is Non Inferior to Double Unit Transfusion in Patients with Hematological Disorders Receiving Allogeneic or Autologous Bone Marrow Transplant or Induction Chemotherapy for Acute Leukemia: The 1versus2 Prospective Multicentric Randomized Clinical Trial Blood Sylvain Chantepie, Jean-Baptiste Méar et al. 2
3 End-of-treatment 18F-FDG PET/CT in diffuse large B cell lymphoma patients: ΔSUV outperforms Deauville score Leukemia & lymphoma Gandhi Damaj, Jean‐Pierre Vilque et al. 7
4 Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database European Heart Journal - Cardiovascular Pharmacotherapy Joachim Alexandre, Joe‐Elie Salem et al. 42
5 18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients Journal of Nuclear Medicine Sylvain Chantepie, Stéphane Guillouet et al. 15
6 Increased frequencies of circulating and tumor-resident Vδ1+T cells in patients with diffuse large B-cell lymphoma Leukemia & lymphoma Anne‐Claire Gac, Véronique Salaün et al. 17
7 Rituximab maintenance after induction with abbreviated FCR in previously untreated elderly (≥ 65 years) CLL patients: Results of the randomized CLL 2007 SA trial from the French FILO Group (NCT00645606). Journal of Clinical Oncology Caroline Dartigeas, Eric Van Den Neste et al. 5
8 The prognostic value of hematogones in patients with acute myeloid leukemia American Journal of Hematology Sylvain Chantepie, Jean‐Jacques Parienti et al. 5
9 Transfusion strategy in hematological intensive care unit: study protocol for a randomized controlled trial Trials Sylvain Chantepie, Jean-Baptiste Méar et al. 9
10 Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia Leukemia & lymphoma Sylvain Chantepie, Jean-Baptiste Méar et al. 13
11 Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group Haematologica Rémy Gressin, Sylvie Caulet-Maugendre et al. 29
12 Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma Oncology Emmanuel Chamorey, Rémy Gressin et al. 4
13 α-Interferon in Combination With Cytarabine in Children With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Journal of Pediatric Hematology/Oncology Frédéric Millot, Pauline Brice et al. 11
14 Granulocyte Colony-Stimulating Factor After Intensive Consolidation Chemotherapy in Acute Myeloid Leukemia: Results of a Randomized Trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques Journal of Clinical Oncology Jean‐Luc Harousseau, Brigitte Witz et al. 56
15 [Normolipemic plane xanthomas and non-Hodgkins malignant lymphomas]. PubMed R. Jaussaud, Jean‐Pierre Vilque et al. 2
16 Avascular necrosis of the femoral head as a complication of chronic myelogenous leukaemia Skeletal Radiology J. Léone, Jean‐Pierre Vilque et al. 12
17 In vitro study of THP-doxorubicin retention in human leukemic cells using confocal laser microspectrofluorometry. PubMed B. Pignon, Hamid Morjani et al. 6
18 Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients. PubMed B. Pignon, D. Aubert et al. 5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026